Established in 1984, Dr. Reddy’s Laboratories a global pharmaceutical company, operating through three core businesses: Pharmaceutical Services and Active Ingredients, comprising the Active Pharmaceuticals and Custom Pharmaceuticals businesses; Global Generics, which includes branded and unbranded generics; and Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations, and Generic Biopharmaceuticals. The company’s products are marketed globally, with a focus on India, US, Europe and Russia. Dr. Reddy’s conducts NCE research in the areas of metabolic disorders, cardiovascular indications, anti-infectives and inflammation.
Ticker:
DRRD
ISIN:
INE089A01023
Address:
8-2-120/76/1/B, 2nd (click to copy or hover over here to view full address)